Formaldehyde → 5-(Furan-3-yl)-8-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[4,3-a]pyrazine

HRID 1045711Notizen

Reaktionsgleichung

Cl.[O:2]1[CH:6]=[CH:5][C:4]([C:7]2[N:12]3[CH:13]=[N:14][N:15]=[C:11]3[C:10]([N:16]3[CH2:21][CH2:20][NH:19][CH2:18][CH2:17]3)=[N:9][CH:8]=2)=[CH:3]1.C=O.Cl[CH2:25]Cl.C([BH3-])#N.[Na+]>CO>[O:2]1[CH:6]=[CH:5][C:4]([C:7]2[N:12]3[CH:13]=[N:14][N:15]=[C:11]3[C:10]([N:16]3[CH2:17][CH2:18][N:19]([CH3:25])[CH2:20][CH2:21]3)=[N:9][CH:8]=2)=[CH:3]1

Komponenten

Reaktionsbedingungen

Temperatur: 20 °C

Versuchsvorschrift

A 50 mL round bottom flask was charged with 5-(furan-3-yl)-8-(piperazin-1-yl)-[1,2,4]triazolo[4,3-a]pyrazine HCl salt (350 mg, 1.14 mmol), 40% aqueous formaldehyde (20 mL), dichloromethane (20 mL), methanol (20 mL) and sodium cyanoborohydride (245 mg, 3.90 mmol) at 0° C. The resulting mixture was stirred at 20° C. overnight. It was then concentrated in vacuo and the residue was extracted with dichloromethane. The organic layer was washed with brine (10 mL), dried over anhydrous Na2SO4, and concentrated in vacuo. The crude product was re-crystallized from a 1/5 (v/v) dichloromethane/ethyl ether, to afford 0.16 g (49%) of the product as a yellow solid. 1H NMR (300 MHz, CDCl3) δ: 8.83 (s, 1H), 7.76 (dd, J=1.5, 0.9 Hz, 1H), 7.62 (dd, J=1.8, 1.5 Hz, 1H), 7.36 (s, 1H), 6.68 (dd, J=1.8, 0.9 Hz, 1H), 4.41 (br, 4H), 2.59 (t, J=5.1 Hz, 4H), 2.36 (s, 3H). MS m/z: 285 (M+H+).

Aufarbeitung

concentrationIt was then concentrated in vacuo
extractionthe residue was extracted with dichloromethane
washThe organic layer was washed with brine (10 mL)
dry with materialdried over anhydrous Na2SO4
concentrationconcentrated in vacuo
customThe crude product was re-crystallized from a 1/5 (v/v) dichloromethane/ethyl ether

Quellen und Nachweise

ORD-Eintrag: ord-8c715ad0d14443ceae3ea843dfd6a821
Quelldatensatz: uspto-grants-2013_10
DOI: 10.6084/m9.figshare.5104873.v1
Patentnummer: US08569300B2

Notizen zur Reaktion

Wird geladen…